"Contrast enhancement is much more useful in the setting of a post-prostatectomy patient, in whom a small focus/foci of enhancement in the operative bed is suspicious for recurrent disease."
"The role of dynamic contrast enhancement in routine evaluation for prostate cancer is uncertain. At the present time its value in addition to T2W and diffusion sequence is considered modest 4. In PI-RADS version 2.1, "suspicious" enhancement (focal early enhancement) is considered a minor feature in evaluation."
"PI-RADS"
"Ktrans"
Expected headings
"Protocol and equipment"
"Limitations"
"Assessment"